title: Utilization of Alcohol Treatment Among HIV-Positive Women with Hazardous Drinking.
abstract: Hazardous alcohol consumption has been frequently reported among women with HIV infection and is associated with a variety of negative health consequences. Treatments to reduce alcohol use may bring in health benefits. However, little is known regarding the utilization of alcohol treatment services among HIV+ women with hazardous drinking. Using data from the Women's Interagency HIV Study (WIHS), this study assessed utilization of any alcohol treatment in the past 6 months and performed multivariable logistic regression to determine correlates of receipt of any alcohol treatment. Among 474 HIV+ women reporting recent hazardous drinking, less than one in five (19%) reported recent utilization of any alcohol treatment. Alcoholics Anonymous (AA) was the most commonly reported (12.9%), followed by inpatient detoxification (9.9%) and outpatient alcohol treatment program (7.0%). Half (51%) receiving any alcohol treatment reported utilization of multiple treatments. Multivariable analyses found alcohol treatment was more often utilized by those who had social support (odds ratio [OR]=1.68, 95% confidence interval [CI]=1.00 to 2.83), fewer economic resources (income ≤$12,000 vs. >$12,000, OR=3.10, 95% CI=1.53 to 6.27), higher levels of drinking (16-35 drinks/week vs. 12-15 drinks/week, OR=3.02, 95% CI=1.47 to 6.21; 36+ drinks/week vs. 12-15 drinks/week, OR=4.41, 95% CI=2.03 to 9.59), and those who reported any illicit drug use (OR=2.77, 95% CI=1.44 to 5.34). More efforts are needed to enhance the utilization of alcohol treatment. Our findings highlight the unique profile of those who utilized alcohol treatment. Such information is vital to improve treatment delivery to address unmet need in this particular population.
authors.affiliation: Department of Epidemiology, College of Public Health and Health Professions, College of Medicine, University of Florida, Gainesville, FL, USA. Electronic address: xingdi.hu@gmail.com.
authors.forename: Xingdi
authors.initials: X
authors.lastname: Hu
authors.affiliation: Behavioral Sciences and Social Medicine, College of Medicine, Florida State University, Tallahassee, FL, USA.
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Harman
authors.affiliation: Department of Epidemiology, College of Public Health and Health Professions, College of Medicine, University of Florida, Gainesville, FL, USA; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA.
authors.forename: Almut G
authors.initials: AG
authors.lastname: Winterstein
authors.affiliation: The Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.
authors.forename: Yue
authors.initials: Y
authors.lastname: Zhong
authors.affiliation: Department of Medicine, University of California, San Francisco and Department of Veterans Affairs Medical Center, San Francisco, CA, USA.
authors.forename: Amber L
authors.initials: AL
authors.lastname: Wheeler
authors.affiliation: College of Medicine, State University of New York Downstate Medical Center, Brooklyn, NY, USA.
authors.forename: Tonya N
authors.initials: TN
authors.lastname: Taylor
authors.affiliation: Georgetown University Medical Center, Department of Medicine, Division of Infectious Diseases, Washington, DC, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Plankey
authors.affiliation: Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
authors.forename: Anna
authors.initials: A
authors.lastname: Rubtsova
authors.affiliation: Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL, USA.
authors.forename: Karen
authors.initials: K
authors.lastname: Cropsey
authors.affiliation: Department of Medicine, Stroger Hospital of Cook County Health and Hospital System and Rush University, Chicago, IL, USA.
authors.forename: Mardge H
authors.initials: MH
authors.lastname: Cohen
authors.affiliation: Division of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
authors.forename: Adaora A
authors.initials: AA
authors.lastname: Adimora
authors.affiliation: Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
authors.forename: Joel
authors.initials: J
authors.lastname: Milam
authors.affiliation: Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
authors.forename: Adebola
authors.initials: A
authors.lastname: Adedimeji
authors.affiliation: Department of Epidemiology, College of Public Health and Health Professions, College of Medicine, University of Florida, Gainesville, FL, USA.
authors.forename: Robert L
authors.initials: RL
authors.lastname: Cook
mesh_terms: D000293:Adolescent; D000328:Adult; D000428:Alcohol Drinking; D019973:Alcohol-Related Disorders / Q000628:therapy*; D005260:Female; D015658:HIV Infections; D006801:Humans; D010349:Patient Compliance; D012959:Socioeconomic Factors; D016320:Substance Abuse Treatment Centers; D011795:Surveys and Questionnaires; D014481:United States; D016387:Women's Health; D055815:Young Adult
keywords: Alcohol treatment; Hazardous drinking; Social support; Utilization; Women with HIV